NCT05945745View on ClinicalTrials.gov

Molecular Analysis and Treatment Options of SCLC

RecruitingOBSERVATIONAL

Enrollment

500

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions

Small-cell Lung CancerSmall Cell Lung Cancer, Combined TypeSmall Cell Lung CarcinomaSmall Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Limited Stage

Interventions

DRUG

Chemotherapy

different treatments based on the molecular analysis

Trial Locations (1)

Unknown

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors

lead

Shanghai Chest Hospital

OTHER

NCT05945745 - Molecular Analysis and Treatment Options of SCLC | Biotech Hunter | Biotech Hunter